ifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a randomised control trial

Sheffield Teaching Hospitals NHS Foundation Trust (UK)0 sites100 target enrollmentSeptember 3, 2010

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Men with advanced prostate cancer receiving androgen suppression therapy
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust (UK)
Enrollment: 100
Status: Completed
Last Updated: 11 years ago

No summary available.

Registry

who.int

Start Date

September 3, 2010

End Date

TBD

Last Updated

11 years ago

Study Type

Interventional

Sex

Male

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust (UK)

•1\. Histologically confirmed, non\-localised prostate cancer (PCa)
•2\. Stable disease (stable prostate specific antigen \[PSA])
•3\. Receiving Androgen suppression therapy (AST) for a minimum period of six months
•4\. A willingness to comply with the randomised allocation to intervention and willing to undertake the requirements of the allocated intervention. If allocated to the exercise intervention, willing to aim to achieve 80% compliance to the exercise intervention.

•1\. Participation in regular physical activity (defined as purposeful physical activity of a moderate intensity for 30 minutes three or more times per week in the previous six months)
•2\. Unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers
•3\. Uncontrolled painful or unstable bone lesions
•4\. Less than two months post surgical treatment
•5\. Any physical, neurological or psychiatric impairment or disease such as dementia, multiple sclerosis, severe arthritis or other condition that would limit the ability to understand and complete the study exercises and complete the required questionnaires, recall and record of dietary information